2547. Targeting penicillin-binding protein 2 (PBP2) to treat metallo-beta-lactamase (MBL)-producing Klebsiella pneumoniae: Mecillinam as an American Ninja Warrior

BACKGROUND: ‘Nightmare’ MBL gram-negatives resistant to nearly all antibiotics have emerged in the clinical setting and are a cause for concern. Here, we assessed the role of targeted PBP2 binding using mecillinam (MEC), which is currently available in other countries and has high affinity for PBP2,...

Descripción completa

Detalles Bibliográficos
Autores principales: Klem, Jack F, Candidate, Pharm D, Kaur, Jan Naseer, Smith, Nicholas M, Chen, Al, Holden, Patricia N, Bulitta, Jürgen B, Tsuji, Brian T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677522/
http://dx.doi.org/10.1093/ofid/ofad500.2164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677522/
http://dx.doi.org/10.1093/ofid/ofad500.2164

Ejemplares similares